BioSig Technologies, based in Westport, Connecticut, develops the PURE EP Platform, a non-invasive device that enhances electrocardiographic signals to improve cardiac ablation procedures. The company went public on September 22, 2014, and employs four people.
Biosig Technologies (BSGM) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Biosig Technologies's actual EPS was -$0.03, beating the estimate of -$0.17 per share, resulting in a 82.70% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.